Michael Gelband’s Morgan Stanley MS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-12,900
Closed -$1.62M 1803
2024
Q4
$1.62M Buy
12,900
+9,900
+330% +$1.22M 0.01% 792
2024
Q3
$313K Sell
3,000
-35,300
-92% -$3.55M ﹤0.01% 1349
2024
Q2
$3.73M Sell
38,300
-28,200
-42% -$2.68M 0.03% 528
2024
Q1
$6.26M Buy
+66,500
New +$5.86M 0.05% 326
2022
Q3
Sell
-200,000
Closed -$15.2M 2145
2022
Q2
$15.2M Hold
200,000
0.19% 118
2022
Q1
$17.5M Buy
+200,000
New +$19.3M 0.22% 76

Other funds holding MS

Michael Gelband's MS Position: Q2 2026 in Review

Michael Gelband sold out of Morgan Stanley (MS) in Q2 2026, closing a stake of 118,759 shares — an estimated $19.5M sold.

Michael Gelband first reported a position in MS in Q2 2019 and held it in 21 quarters. The position peaked at $41.9M in Q3 2021. 2,722 funds tracked by Wall St. Rank hold MS as of Q2 2026.

  • Michael Gelband reported no remaining Morgan Stanley position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 118,759 Morgan Stanley shares in Q2 2026, an estimated $19.5M.
  • Michael Gelband first reported a position in Morgan Stanley in Q2 2019 and held it in 21 quarters.
  • Michael Gelband's Morgan Stanley position peaked at $41.9M in Q3 2021.
  • 2,722 funds tracked by Wall St. Rank held Morgan Stanley as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.